BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21354567)

  • 1. An unusual cause of small-intestine mucosal pigmentation.
    Raftopoulos SC; Fermoyle S
    Gastrointest Endosc; 2011 Jun; 73(6):1285-6. PubMed ID: 21354567
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
    Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
    Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does thalidomide have a role in leprosy?
    Crawford CL
    Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
    [No Abstract]   [Full Text] [Related]  

  • 6. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 7. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of erythema nodosum leprosum: current and future options.
    Lockwood DN
    Lepr Rev; 1996 Dec; 67(4):253-9. PubMed ID: 9033196
    [No Abstract]   [Full Text] [Related]  

  • 10. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrotic erythema nodosum leprosum with oral mucosal involvement.
    Swain JP; Soud A; Agarwal SK
    Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns regarding in vitro and in vivo uses of thalidomide.
    Tadesse A; Shannon EJ
    Lepr Rev; 2005 Mar; 76(1):94-6. PubMed ID: 15881041
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent erythema nodosum leprosum precipitated by antileprosy drugs.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):458-9. PubMed ID: 9030118
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparing for thalidomide's comeback.
    Vanchieri C
    Ann Intern Med; 1997 Nov; 127(10):951-2. PubMed ID: 9446509
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
    Bhargava P; Kuldeep CM; Mathur NK
    Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
    [No Abstract]   [Full Text] [Related]  

  • 17. No role for thalidomide in the treatment of leprosy.
    Crawford CL
    J Infect Dis; 2006 Jun; 193(12):1743-4; author reply 1744-5. PubMed ID: 16703522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin-induced urticaria in leprosy.
    Sharma VK; Kaur I; Vatve M; Kumar B
    Lepr Rev; 1997 Dec; 68(4):331-2. PubMed ID: 9503869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.